An Intervention Program to Control Diabetes

This study has been completed.

Sponsor:

Information provided by:

Abbott Nutrition

ClinicalTrials.gov Identifier:

NCT00543621

First received: October 12, 2007

Last updated: NA

Last verified: October 2007

History: No changes posted

Purpose

Study to evaluate the effectiveness of a structured intervention to improve diabetes control.

Condition	Intervention	Phase
Diabetes Mellitus, Type 2	Other: daily enteral nutritional product and/or behavioral changes	Phase 4


Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	An Intervention Program to Control Diabetes

Further study details as provided by Abbott Nutrition:

Primary Outcome Measures:

HbA1c, Fasting blood glucose,blood pressure, weight loss [ Time Frame: 24 weeks ]


Enrollment:	150
Study Start Date:	May 2005

Eligibility


Ages Eligible for Study:	18 Years to 70 Years (Adult, Senior)
Sexes Eligible for Study:	All

Criteria

Inclusion Criteria:

informed consent
18-70 adults
Type 2 Diabetes
Males and non-pregnant females

Exclusion Criteria:

Use of exogenous insulin for glucose control
Use of medications or supplements for weight loss
Advanced diabetes complications
Recent history of cardiovascular event

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00543621

Locations


China
Huandong Hospital
Shanghai, China

Sponsors and Collaborators

Abbott Nutrition

Investigators


Principal Investigator:	Jianqin Sun, MD, MPH	Clinical Nutrition Center, Huadong Hospital

More Information


ClinicalTrials.gov Identifier:	NCT00543621 History of Changes
Other Study ID Numbers:	Welltech Study
Study First Received:	October 12, 2007
Last Updated:	October 12, 2007

Additional relevant MeSH terms:


Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases

ClinicalTrials.gov processed this record on June 23, 2017

To Top